Glucocorticoid receptor drugs for Chronic Obstructive Pulmonary Disease
2 tracked Glucocorticoid receptor drugs in the Chronic Obstructive Pulmonary Disease race. The class explanation lives on the Glucocorticoid receptor page; the full indication pipeline across every mechanism is on the Chronic Obstructive Pulmonary Disease page.
2 approved / phase 4
Head-to-head evidence: fluticasone furoate/umeclidinium/vilanterol vs fluticasone furoate/vilanterol